Sun damage,
redness and dyschromia.
Australia's UV environment makes pigmentation and surface vascularity the highest-volume corrective indication in the country. The Octave platform handles both — with selectable IPL filters for surface pigment and broken capillaries, and a Q-switched Nd:YAG handpiece for deeper, more stubborn lesions.
“I'm so over my pigmentation. I just want my skin to look even — without the seven products I'm currently using.”
Mode-of-action,
explained simply.
The 510 nm long-pass filter targets superficial epidermal pigment — freckles, lentigines, light café-au-lait — using selective photothermolysis of melanin in the basal layer.
The 420 nm filter is the workhorse for telangiectasia and surface vascular lesions. Hemoglobin absorbs strongly at this wavelength, allowing precise vessel-specific photocoagulation.
For deeper dermal pigment, melasma flares and tattoo remnants. The 1064 nm Q-switched pulse delivers high-peak-power photoacoustic energy with minimal thermal injury to surrounding tissue.
IPL combined with radiofrequency in a single pulse — useful for deeper vascular lesions and recalcitrant pigment where IPL alone is reaching its therapeutic ceiling.
A treatment journey
that scales with the patient.
Each Power to Practice indication ships with a written, editable protocol — built around realistic patient outcomes and the operator workflow of an Australian aesthetic clinic.
- 01Consult, photo & Fitzpatrick typing
Mandatory before treatment. Identify lesion type (epidermal vs. dermal, vascular vs. pigmented). Rule out melasma activity, recent sun exposure, and photosensitiser use.
- 02Test patch (first visit)
Standard test-patch protocol on a discrete area. Assess endpoint at 24 hours and 7 days before proceeding to full treatment.
- 03Treatment series (3–5 sessions)
Sessions spaced 4–6 weeks apart depending on indication. Photographic review at every session. Filter selection adjusts as the response evolves.
- 04Maintenance
Annual or bi-annual touch-up sessions. Strong emphasis on at-home SPF compliance — record this in the patient file at every visit.
Run this indication on the platforms we already support.
The numbers your finance person cares about.
Indicative figures based on Australian aesthetic clinic averages. Speak to our team for a tailored revenue and capex model for your specific patient base and treatment menu.
Common questions from clinics.
Can the Octave platform treat melasma safely?
Melasma requires careful patient selection and conservative parameters. The Q-switched 1064 nm Nd:YAG handpiece is the manufacturer-indicated modality for melasma — IPL is generally avoided due to the risk of post-inflammatory hyperpigmentation. Patient counselling and dermatology referral pathways should be in place before offering this indication.
What's the operator training requirement?
Operator onboarding is included with every Octave install. We deliver remote live-video training, written SOPs and post-onboarding competency review for IPL and Nd:YAG modalities. Ongoing clinical mentorship is available for complex cases.
Can I run pigmentation and vascular ads under TGA?
Yes — these are device-based treatment indications. The Octave platform itself is TGA-included. Refer to AHPRA's professional advertising framework for general advertising rules and avoid before/after imagery in compliance with that framework.
What's the contraindication list look like?
Pregnancy, recent sun exposure (3–4 weeks), photosensitising medication, active skin infection or dermatosis in the area, history of skin cancer in the area, recent isotretinoin use (within 6 months), and Fitzpatrick VI for IPL specifically (use Nd:YAG instead). Full screening checklist is provided in the operator SOP supplied at install.